Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer (Q33774527)

29 July 2017

Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer (English)

1 reference

29 July 2017

1 reference

9

Dawn L Hershman

1 reference

29 July 2017

2

Cande V Ananth

1 reference

29 July 2017

1

Jason D Wright

1 reference

29 July 2017

7

Alfred I Neugut

1 reference

29 July 2017

Jennifer Tsui

3

1 reference

29 July 2017

Sherry A Glied

4

1 reference

29 July 2017

William M Burke

5

1 reference

29 July 2017

Yu-Shiang Lu

6

1 reference

29 July 2017

Thomas J Herzog

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

17 January 2014

1 reference

29 July 2017

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

29 July 2017

120

1 reference

29 July 2017

8

1 reference

29 July 2017

1246-1254

1 reference

Methods in comparative effectiveness research

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Survival implications associated with variation in mastectomy rates for early-staged breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Reducing bias in the assessment of treatment effectiveness: androgen deprivation therapy for prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Postoperative radiotherapy for elderly patients with stage III lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Introduction to propensity scores: A case study on the comparative effectiveness of laparoscopic vs open appendectomy.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062652

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

28 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Development of a comorbidity index using physician claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Incorporation of bevacizumab in the primary treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28508

Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?

21 January 2018

1 reference

12 December 2020

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease

1 reference

12 December 2020

Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer

1 reference

12 December 2020

Is the easier way ever the better way?

1 reference

12 December 2020

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

1 reference

12 December 2020

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival

1 reference

12 December 2020

Assessing illness severity: does clinical judgment work?

1 reference

12 December 2020

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists

1 reference

12 December 2020

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.28508

1 reference

29 July 2017

1 reference

29 July 2017

1 reference